2019-nCoV

Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.  

The antiviral disables RNA replication machinery in MERS and SARS viruses. Can it beat back SARS-CoV-2?

There is no evidence backing the idea that SARS-CoV-2 originated from US servicemembers visiting Wuhan.

The WHO chief calls for swift action as universities in multiple countries shut down and researchers report kids can become infected.

Administration officials have given contradictory statements about how COVID-19 will affect the US, and it is not clear who is leading the infectious disease response effort, critics say.

A patient in California acquired COVID-19 despite not traveling to an affected area or having contact with anyone who did.

Random mutations in the SARS-CoV-2 pathogen’s genome help researchers track the spread and transmission of COVID-19, the disease it causes.

An increase in confirmed infections, particularly in Italy, Iran, and South Korea, has led to heightened measures to prevent the spread of the virus SARS-CoV-2.

Emerging data as well as knowledge from the SARS and MERS coronavirus outbreaks yield some clues as to why SARS-CoV-2 affects some people worse than others.

Liu Zhiming is the eighth frontline health-care worker to die from COVID-19, and hundreds more have been infected.

The National Institute of Allergy and Infectious Diseases releases a series of images that offer a close up look at the novel coronavirus SARS-CoV-2.

Scientists can provide essential information to educate the public about the coronavirus.

Nearly 100 academic journals, societies, institutes, and companies sign a commitment to make research and data on COVID-19 freely available, at least for the duration of the outbreak.

Researchers find 380 amino acid substitutions between 2019-nCoV and severe acute respiratory syndrome (SARS)-related coronaviruses.

Authorities had silenced Li Wenliang after he spoke out about the virus, now known as 2019-nCoV, in the early days of the epidemic.

Critics of the practice say the guidance is irresponsible and could give users a false sense of security.

The US Food and Drug Administration authorizes the distribution of the 2019-nCoV diagnostic to state health departments and other facilities.

Claims that a woman spread the virus to a colleague in Germany before she had symptoms conflict with health officials’ interview with the patient herself.

Combining the medications improved conditions in patients with severe 2019-nCoV infections, say doctors in Thailand.